EntryPoint Capital’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,005
| Closed | -$168K | – | 648 |
|
|
2025
Q1 | $168K | Sell |
28,005
-24,341
| -47% | -$146K | 0.08% | 572 |
|
|
2024
Q4 | $408K | Buy |
+52,346
| New | +$408K | 0.17% | 197 |
|
|
2024
Q2 | – | Sell |
-31,292
| Closed | -$210K | – | 1006 |
|
|
2024
Q1 | $210K | Sell |
31,292
-1,751
| -5% | -$11.8K | 0.19% | 100 |
|
|
2023
Q4 | $194K | Buy |
+33,043
| New | +$194K | 0.19% | 102 |
|